Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 5, 2025, 8:00 PM EDT
Poniard Pharmaceuticals Market Cap
Poniard Pharmaceuticals has a market cap or net worth of $150.00 as of August 7, 2025. Its market cap has decreased by -99.68% in one year.
Market Cap
150.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 11, 1988, Poniard Pharmaceuticals's market cap has decreased from 100.37M to 150.00, a decrease of -100.00%. That is a compound annual growth rate of -30.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 150.00 | 14,900.00% |
| Dec 30, 2021 | 1.00 | -100.00% |
| Dec 31, 2020 | 49.47K | 80.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 474.59M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |